Home

свидетелствувам бунище патологичен constant ratio drug design nature 2016 всеотдайност Спокоен принцеса

Automating drug discovery | Nature Reviews Drug Discovery
Automating drug discovery | Nature Reviews Drug Discovery

The Time and Place for Nature in Drug Discovery | JACS Au
The Time and Place for Nature in Drug Discovery | JACS Au

Exploring protein hotspots by optimized fragment pharmacophores | Nature  Communications
Exploring protein hotspots by optimized fragment pharmacophores | Nature Communications

Late-stage C–H functionalization offers new opportunities in drug discovery  | Nature Reviews Chemistry
Late-stage C–H functionalization offers new opportunities in drug discovery | Nature Reviews Chemistry

Designing hydrogels for controlled drug delivery | Nature Reviews Materials
Designing hydrogels for controlled drug delivery | Nature Reviews Materials

A combined high-throughput and high-content platform for unified on-chip  synthesis, characterization and biological screening | Nature Communications
A combined high-throughput and high-content platform for unified on-chip synthesis, characterization and biological screening | Nature Communications

Counting on natural products for drug design | Nature Chemistry
Counting on natural products for drug design | Nature Chemistry

A machine learning-based chemoproteomic approach to identify drug targets  and binding sites in complex proteomes | Nature Communications
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications

New strategy for drug discovery by large-scale association analysis of  molecular networks of different species | Scientific Reports
New strategy for drug discovery by large-scale association analysis of molecular networks of different species | Scientific Reports

Evaluating drug targets through human loss-of-function genetic variation |  Nature
Evaluating drug targets through human loss-of-function genetic variation | Nature

MuSyC is a consensus framework that unifies multi-drug synergy metrics for  combinatorial drug discovery | Nature Communications
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications

Advances in covalent drug discovery | Nature Reviews Drug Discovery
Advances in covalent drug discovery | Nature Reviews Drug Discovery

Avidity in antibody effector functions and biotherapeutic drug design |  Nature Reviews Drug Discovery
Avidity in antibody effector functions and biotherapeutic drug design | Nature Reviews Drug Discovery

A unified drug–target interaction prediction framework based on knowledge  graph and recommendation system | Nature Communications
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications

Network-based approach to prediction and population-based validation of in  silico drug repurposing | Nature Communications
Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications

DNA-encoded chemistry: enabling the deeper sampling of chemical space |  Nature Reviews Drug Discovery
DNA-encoded chemistry: enabling the deeper sampling of chemical space | Nature Reviews Drug Discovery

A rational blueprint for the design of chemically-controlled protein  switches | Nature Communications
A rational blueprint for the design of chemically-controlled protein switches | Nature Communications

Strategies and challenges for the next generation of antibody–drug  conjugates | Nature Reviews Drug Discovery
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery

Modulating biomolecular condensates: a novel approach to drug discovery |  Nature Reviews Drug Discovery
Modulating biomolecular condensates: a novel approach to drug discovery | Nature Reviews Drug Discovery

The expanding role for small molecules in immuno-oncology | Nature Reviews Drug  Discovery
The expanding role for small molecules in immuno-oncology | Nature Reviews Drug Discovery

Immune targets for therapeutic development in depression: towards precision  medicine | Nature Reviews Drug Discovery
Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery

Improving Drug Candidates by Design: A Focus on Physicochemical Properties  As a Means of Improving Compound Disposition and Safety | Chemical Research  in Toxicology
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety | Chemical Research in Toxicology

Effective drug combinations in breast, colon and pancreatic cancer cells |  Nature
Effective drug combinations in breast, colon and pancreatic cancer cells | Nature